Idxg stock.
Interpace Biosciences Inc (OTC:IDXG) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds (or held) more ...
Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Interpace Biosciences Inc have a median target of 11.00, with a high estimate of 11.00 and a low estimate of 11.00. The median estimate represents a +909.17% increase from the last price of 1.09. Chart unavailable.Get the latest OTC Markets Group Inc (OTCM) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Analyst Sentiment - World. United States Canada UK Hong Kong Japan Australia New Zealand. Germany Switzerland Spain Poland Netherlands Greece France Ireland Italy Belgium Austria Israel Türkiye6201 15th Avenue. Brooklyn, NY 11219. T: 718-921-8300. [email protected]. www.astfinancial.com. Interpace Biosciences® is a dynamic and growing leader in the life sciences industry, providing complex molecular analysis for the early diagnosis and treatment of cancer. Interpace Biosciences is a fully integrated commercial and ...
A solid price increase over a period of 12 weeks reflects investors' continued willingness to pay more for the potential upside in a stock. IDXG is quite a good fit in this regard, gaining 42.5% ...Interpace Biosciences, Inc. (IDXG) Stock Price, Quote & News - Stock Analysis Interpace Biosciences, Inc.) No 1Y chart data available IDXG In 2022, IDXG's …--- - Interpace Biosciences, Inc. (NASDAQ:IDXG) major shareholder Peter Kamin bought 83,250 shares of the companys stock in a transaction that occurred on Monday, March 1st. The stock was bought at an average price of $3.12 per share, with a total value of $259,740.00.
© Valve Corporation. All rights reserved. All trademarks are property of their respective owners in the US and other countries. #footer_privacy_policy | #footer ...
Gregory Richard - IDXG / Interpace Diagnostics Group, Inc. - Insider Trade Report ... (Stocks) Options Flow - Last 7 Days (ETF) Gamma Squeeze; Gamma Pockets; Put/Call Ratio - Top Bullish; Put Call Ratio - Top Bearish; SEC FILINGS SEC Forms Latest S1 (IPO) Filings Latest 13D/G Filings Latest 13F Filings. SCREENERGet the latest Interpace Biosciences, Inc. (IDXG) stock news and headlines to help you in your trading and investing decisions.Find the latest Interpace Biosciences, Inc. (IDXG) stock quote, history, news and other vital information to help you with your stock trading and investing. Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-3.59 Market Cap $3.59 M Shares Outstanding 4.32 M Public Float 3.09 M Yield IDXG is not currently paying a regular dividend. Latest Dividend N/A...
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here.By continuing to use our site, you ...
The Price to Sales ratio or P/S is calculated as price divided by sales. After the P/E ratio, it's one of the most common valuation metrics. If the P/S ratio is 1, that means you're paying $1 for ...
Interpace Diagnostics to Present New Data in Six Posters Related to PancraGEN™ at Upcoming Annual DDW International Meeting on May 6-9, 2017 PR Newswire1.31. Shareholder percentage totals can add to more than 100% because some holders are included in the free float. The latest Interpace Biosciences stock prices, stock quotes, news, and IDXG ...PARSIPPANY, NJ, Jan. 12, 2022 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced that it commenced its previously announced fully back-stopped Rights Offering of up to $30 million. Under the terms of the Rights Offering, the Company is distributing non-transferable subscription …Real stock prices are not the same as the last traded stock price. Real stock prices are adjustments to closing stock prices. The adjustments are used in a variety of ways, including dividends, the range of prices and the closing price of t...IDXG is the ticker symbol for Interpace Biosciences, Inc., a company that provides molecular diagnostic tests for cancer and other diseases. The stock price, news, quote and history …Gregory Richard - IDXG / Interpace Diagnostics Group, Inc. - Insider Trade Report ... (Stocks) Options Flow - Last 7 Days (ETF) Gamma Squeeze; Gamma Pockets; Put/Call Ratio - Top Bullish; Put Call Ratio - Top Bearish; SEC FILINGS SEC Forms Latest S1 (IPO) Filings Latest 13D/G Filings Latest 13F Filings. SCREENER
The Price to Sales ratio or P/S is calculated as price divided by sales. After the P/E ratio, it's one of the most common valuation metrics. If the P/S ratio is 1, that means you're paying $1 for ... IDXG Message Board Parsippany, NJ, April 22, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG ) today issued the following statement. Interpace continues to make progress executing its growth strategy and the Company recently increased 2021 revenue guidance.home / stock / idxg / idxg news. RSS . IDXG IDXG Quote IDXG Short IDXG News IDXG Articles IDXG Message Board. March, 31 2021 05:20 PM | GlobeNewswire | More on IDXG. IDXG; IDXG Quote; IDXG Short; IDXG News; IDXG Articles; IDXG Message Board; 2020 Full Year Net Revenue of $32.4 Million Up 34% vs Prior Year; Fourth Quarter Net …Dr D IDXG stock SEC Form 4 insiders trading. Dr has made over 1 trades of the Interpace Biosciences Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he bought 10,855 units of IDXG stock worth $94,221 on 21 May 2021.10,855 units of IDXG stock worth $94,221 on 21 May 2021.Nov 28, 2023 · EPS is the net income, or profit, a company generates during a period for each share of common stock it has outstanding. Zacks News for IDXG TherapeuticsMD (TXMD) Reports Q3 Loss, Lags Revenue ... Interpace Diagnostics Announces New Partnership with Israeli Specialty Services Provider PR Newswire PARSIPPANY, N.J., Jan. 20, 2017 PARSIPPANY, N.J. , Jan. 20,
Lihat berita, harga saham, data fundamental, teknikal analisis dan laporan keuangan saham IDXG30 (IDX Growth 30) Investasi, Nabung, Beli atau Jual sahamnya secara online dengan mudah.
A list of the latest Interpace Biosciences Inc News - IDXG Stock News, Press Releases, Earnings Report, Financial Disclosures, Offerings, Acquisitions.ISIN. US46062X3035. Interpace Biosciences, Inc. engages in the development and sale of diagnostic clinical and pharma services. It offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion molecular test, ThyGenX, an expanded oncogenic mutation panel that helps identify malignant thyroid nodules, ThyraMIR, which assesses thyroid ...The 60 rating InvestorsObserver gives to Interpace Biosciences Inc stock puts it near the top of the Diagnostics & Research industry. In addition to scoring higher than 71 percent of stocks in the Diagnostics & Research industry, IDXG’s 60 overall rating means the stock scores better than 60 percent of all stocks.Here are the reasons to buy IDXG stock: IDXG stock price ($1.77) is close to the 52-week low ($1.70). Perhaps now is a good time to buy? See IDXG price chart. IDXG forward P/E ratio is 3.08, which is low compared to its industry peers’ …We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here.By continuing to use our site, you ...Analyst Sentiment Leaderboard. DIVIDENDS Dividend Calendar Dividends - WorldJul 24, 2017 · IDXG is important to the diagnostics industry. The company has been transformed. Seeking Alpha - Go to Homepage. Trending. My Portfolio. My Authors. Top Stocks. Latest News. Markets. Stock Ideas. U.S. Stock Market Overview Top Analyst Stocks Top Smart Score Stocks Top Insiders Stocks. Popular. Stock Screener Top Online Growth Stocks. New. Trending Stocks Penny Stock Screener. Dividend Investing. Dividend Calculator Dividend Yield Calculator. New. Dividend Stocks Dividend News Dividend Calendar.Interpace Biosciences Inc (OTCQX US:IDXG) Interpace Biosciences Inc. 1.05. Delayed Data. As of Nov 21. -0.09 / -7.89%. Today’s Change. 0.51. Today ||| 52-Week Range.
Nov 30, 2023 · Interpace Biosciences Completes Sale of Its Pharma Services Business to Flagship Biosciences, Inc. PARSIPPANY, NJ, Aug. 31, 2022 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (OTCQX: IDXG) (“Interpace” or the “Company”), a leader in enabling personalized medicine, has announced the closing of a d... 1 year ago - GlobeNewsWire.
PARSIPPANY, NJ, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (NASDAQ: IDXG) (“Interpace” or the “Company”), a leader in enabling personalized medicine, today announced that on February 16, 2020 it had received notification from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock market LLC (“Nasdaq”) that …
IDXG Earnings Date and Information. Interpace Biosciences last issued its earnings results on November 8th, 2023. The business services provider reported ($0.12) EPS for the quarter. The business had revenue of $9.08 million for the quarter.Establishing ownership of stock depends on how the stock was purchased, according to the Securities and Exchange Commission. A brokerage firm may have purchased the stock or it may have been bought directly from the company.IDXG - Interpace Diagnostics Changes Name to Interpace Biosciences; Announces Plans for Next Phase of Growth and Third Quarter 2019 Financial Results. home / stock / idxg / idxg news. RSS . IDXG IDXG Quote IDXG Short IDXG News IDXG Articles IDXG Message Board. November, 13 2019 04:40 PM | GlobeNewswire | More on IDXG …Oct 20, 2020 · What's Happening With IDXG Stock Today? Interpace Biosciences Inc (IDXG) stock is trading at $3.33 as of 1:58 PM on Tuesday, Oct 20, a decline of -$0.66, or -16.62% from the previous closing price of $3.99. The stock has traded between $3.22 and $3.81 so far today. Volume today is less active than usual. Discover the top 3 undervalued Managed Health care stocks for Monday, November 20 based on AAII’s Stock Grades. Eunice Kim. Stock Grade Focus Is Interpace Biosciences Inc (IDXG) Stock a Good Investment?Complete Interpace Biosciences Inc. stock information by Barron's. View real-time IDXG stock price and news, along with industry-best analysis.Portfolio Builder / Fund Intersect. China Equity Emerging Markets Gold and Silver International Dividend US Dividend US Energy US High Dividend US Large Cap Growth US Large Cap Value US Mid Cap Growth US Mid Cap Value US REIT US Small Cap Growth US Small Cap Value US Sustainable (ESG)Parsippany, NJ, May 03, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) announced today that eviCore Healthcare (“eviCore”), a wholly owned subsidiary of Cigna, has updated their laboratory management guidelines to include positive coverage for ThyGeNEXT ® and ThyraMIR ® .This update, …Find the latest Bioventus Inc. (BVS) stock quote, history, news and other vital information to help you with your stock trading and investing.
PARSIPPANY, NJ, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (NASDAQ: IDXG) (“Interpace”), a leader in enabling personalized medicine, issued the following communication to shareholders: Dear Shareholders, As the newly appointed President and CEO of Interpace I want to take a moment to formally introduce myself …Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools. Identify stocks that meet your criteria using seven unique stock screeners.Lihat berita, harga saham, data fundamental, teknikal analisis dan laporan keuangan saham IDXG30 (IDX Growth 30) Investasi, Nabung, Beli atau Jual sahamnya secara online dengan mudah.Instagram:https://instagram. kneron stockopen insiderindexrussell ruameli stock forecast The estimated Net Worth of Thomas W. Burnell is at least $437 millier dollars as of 21 May 2021. Dr Burnell owns over 10,855 units of Interpace Biosciences Inc stock worth over $12,158 and over the last 3 years he sold IDXG stock worth over $0. In addition, he makes $425,004 as Pres et CEO & Director at Interpace Biosciences Inc. automated trade systemvm ware stock price Four Million Members Gain in-Network Access. PARSIPPANY, NJ, July 29, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that it has entered in to a contract with Blue Shield of California, a not-for-profit independent member of the Blue Cross Blue Shield Association making …Bringing Insights to Life. Interpace Biosciences® (IDXG) is a dynamic and growing leader in the life sciences industry, providing complex molecular analysis for the early diagnosis and treatment of cancer. best real estate investment app © Valve Corporation. Tutti i diritti riservati. Tutti i marchi appartengono ai rispettivi proprietari negli Stati Uniti e in altri Paesi. #footer_privacy_policy | # ...The Author of the Blog is PENNY STOCKS INC Top 20 Penny Stocks To Buy in Year 2017 Top 17 Penny Stocks to buy in 2017- Below is a list . of the Top 10 Penny Stocks and the Best 10 Penny . Stocks to Buy in 2017. Keep in mind that penny stocks . are very risky so do your own research and figure out of .